Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | P2RY1 | P47900 | 5/20 | 0.58 |
| ▸ | ENPP1 | P22413 | 4/20 | 0.58 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.58 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.58 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.58 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.58 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.58 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.56 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.56 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.56 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.55 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.54 |
| ▸ | GPR17 | Q13304 | 2/20 | 0.53 |
| ▸ | PNP | P00491 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15573313 | 1.00 | NT5E (0.64) | NT5EPOLBP2RY1ENPP1P2RY6 | |
| SCHEMBL21056508 | 0.93 | NT5E (0.62) | NT5EPOLBP2RY1ENPP1P2RY6 | |
| SCHEMBL12932286 | 0.93 | NT5E (0.67) | NT5EPOLBP2RY1ENPP1P2RY6 | |
| SCHEMBL17117823 | 0.93 | NT5E (0.67) | NT5EPOLBP2RY1ENPP1P2RY6 | |
| SCHEMBL345288 | 0.93 | NT5E (0.67) | NT5EPOLBP2RY1ENPP1P2RY6 | |
| SCHEMBL4820794 | 0.93 | NT5E (0.67) | NT5EPOLBP2RY1ENPP1P2RY6 | |
| SCHEMBL29400356 | 0.93 | NT5E (0.67) | NT5EPOLBP2RY1ENPP1P2RY6 | |
| SCHEMBL15793736 | 0.91 | NT5E (0.62) | NT5EPOLBP2RY1ENPP1P2RY6 | |
| 2-Chlorodeoxyadenosine Triphosphate SCHEMBL1064487 | 0.91 | NT5E (0.78) | NT5EPOLBP2RY1ENPP1P2RY6 | |
| 2-Chlorodeoxyadenosine Triphosphate SCHEMBL1064481 | 0.91 | NT5E (0.78) | NT5EPOLBP2RY1ENPP1P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023081883-A2 | METHYLATION SEQUENCING METHODS AND COMPOSITIONS | ULTIMA GENOMICS, INC. (US) | 2023-05-11 | — | — | WO | claimed |
| US-20260120804-A1 | SEQUENCING ALGORITHM | ILLUMINA SINGAPORE PTE LTD (SG) | 2026-04-30 | — | — | US | disclosed |
| EP-4640847-A2 | METHOD FOR PREFERENTIALLY AMPLIFYING NUCLEIC ACID MOLECULES LONGER THAN 1 KBP | Illumina Singapore Pte. Ltd. (SG) | 2025-10-29 | — | — | EP | disclosed |
| EP-4008792-B1 | METHOD FOR INTRODUCING MUTATIONS | ILLUMINA SINGAPORE PTE LTD (SG) | 2025-08-06 | — | — | EP | disclosed |
| US-20250137000-A1 | METHODS OF PREFERENTIALLY AMPLIFYING NUCLEIC ACID MOLECULES | ILLUMINA SINGAPORE PTE LTD (SG) | 2025-05-01 | — | — | US | disclosed |
| US-12203076-B2 | Method for introducing mutations | ILLUMINA SINGAPORE PTE. LTD. (SG) | 2025-01-21 | — | — | US | disclosed |
| EP-4293123-A2 | SEQUENCING ALGORITHM | Illumina Singapore PTE. Ltd. (SG) | 2023-12-20 | — | — | EP | disclosed |
| EP-3950958-B1 | SEQUENCING ALGORITHM | ILLUMINA SINGAPORE PTE LTD (SG) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023081883-A2 | METHYLATION SEQUENCING METHODS AND COMPOSITIONS | ULTIMA GENOMICS, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| US-20220348940-A1 | METHOD FOR INTRODUCING MUTATIONS | ILLUMINA SINGAPORE PTE. LTD. (SG) | 2022-11-03 | — | — | US | disclosed |
| US-11421238-B2 | Method for introducing mutations | Longas Technologies Pty Ltd (AU) | 2022-08-23 | — | — | US | disclosed |
| EP-4008792-A1 | METHOD FOR INTRODUCING MUTATIONS | Longas Technologies Pty Ltd (AU) | 2022-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260120804-A1 | SEQUENCING ALGORITHM | DNMT3A, UPF1, RNMT | NT5E 74/4885POLB 14/4885P2RY1 3080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.